Cargando…
CFTR Modulators in People with Cystic Fibrosis: Real-World Evidence in France
Cystic fibrosis (CF) is a rare genetic multisystemic disease, the manifestations of which are due to mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein and can lead to respiratory insufficiency and premature death. CFTR modulators, which were developed in the pa...
Autores principales: | Regard, Lucile, Martin, Clémence, Burnet, Espérie, Da Silva, Jennifer, Burgel, Pierre-Régis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179538/ https://www.ncbi.nlm.nih.gov/pubmed/35681464 http://dx.doi.org/10.3390/cells11111769 |
Ejemplares similares
-
Major Decrease in Lung Transplantation for Patients with Cystic Fibrosis in France
por: Martin, Clémence, et al.
Publicado: (2021) -
CT imaging shows specific pancreatic abnormalities in persons with cystic fibrosis related diabetes
por: Alexandre-Heymann, Laure, et al.
Publicado: (2023) -
Editorial: Real-world experience with CFTR modulator therapy
por: Tümmler, Burkhard, et al.
Publicado: (2023) -
Change in Lung Function after Initiation of Elexacaftor–Tezacaftor–Ivacaftor: Do Not Forget Anatomy!
por: Martin, Clémence, et al.
Publicado: (2022) -
The Ongoing Quest for Predictive Biomarkers in Chronic Obstructive Pulmonary Disease
por: Regard, Lucile, et al.
Publicado: (2023)